The Decline of Traditional Cigarettes: Russians Switch to E-Cigarettes

Aug.29.2023
The Decline of Traditional Cigarettes: Russians Switch to E-Cigarettes
Russian cigarette sales drop as smokers shift to e-cigarettes and heated tobacco products, according to Rosstat data.

According to data released by the Russian Federal State Statistics Service (Rosstat) on August 28th, the sales volume of regular cigarettes in Russia is declining as smokers are shifting from traditional cigarettes to e-cigarettes and heated tobacco products.


According to the data, the per capita retail sales volume of various types of cigarettes in Saint Petersburg, Russia, showed an average year-on-year decline of 47% from January to June 2023. In the same period last year, from January to June 2022, the average number of cigarettes sold per person per month in Saint Petersburg was 133, while currently it is only 70. Comparing to the results from the first six months of last year, Saint Petersburg sold an average of 70 cigarettes per person per month.


The decrease in cigarette sales in some major cities may be attributed to the growing popularity of new products, including e-cigarettes and heated tobacco products.


Polina Vilichkina, leader of the big data company "Evotor," points out that the decline in regular cigarette sales is a trend in Russia in recent years. However, this does not mean that people are quitting smoking but rather that smokers are shifting from traditional cigarettes to e-cigarettes.


According to Vilichkina, the younger generation is increasingly turning to e-cigarettes rather than traditional cigarettes when they start smoking.


Furthermore, the growth rate of e-cigarette sales is higher than the decline rate of traditional cigarettes.


At the same time, the sales of smokeless nicotine products are also increasing. It is estimated that the number of stores selling Swedish snus has doubled in the past year. Despite Russia banning the sale of Swedish snus since 2015, smokeless nicotine mixtures are not legally restricted at the federal level. However, authorities in some regions, such as the Arkhangelsk Oblast, do not allow the sale of such products.


Experts believe that the unusual nature of sales data in Saint Petersburg may be attributed to a miscalculation in the statistical methods used by the Russian Federal State Statistics Service.


However, experts believe that the decline in official sales might also be genuine, as the data from the National Statistics Bureau is based on tax revenues and does not account for counterfeit products. Given the decrease in people's income, many individuals have started saving money and turned to purchasing goods from the grey market.


According to experts' estimates, there are numerous websites on the internet that offer opportunities to purchase cigarettes at significantly lower prices than the official rates. However, analyst Ivan Fegekov claims that all products sold on these websites are counterfeit.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
From Brands to Supply Chains: 2Firsts Builds a PMTA Compliance Service System for the U.S. Market
2Firsts supports new tobacco and nicotine companies entering the U.S. market with full-chain PMTA compliance services.
Jun.04
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France has officially banned nicotine pouches and other oral nicotine products, including Zyn. The new regulation classifies such products as “toxic substances” and imposes criminal penalties on their use, possession, purchase, and sale. Violators may face up to five years in prison and fines of up to €400,000 (approximately $436,600).
Regulations
May.25
KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion
KT&G Q1 2026 Financial Results: Revenue at $1.156 Billion, E-Cigarettes to Launch Independent Overseas Expansion
KT&G reports a 27.6% increase in Q1 operating profit, with traditional and new tobacco sectors driving growth.
May.07 by 2FIRSTS.ai
BAT AGM Highlights Smokeless Strategy, AI Capability and Regulatory Engagement
BAT AGM Highlights Smokeless Strategy, AI Capability and Regulatory Engagement
BAT Chair Luc Jobin told shareholders at the company’s 2026 Annual General Meeting that BAT delivered on its plans in 2025 despite a challenging external environment, with the U.S. business returning to growth, smokeless consumers increasing by more than 15%, improved New Categories contribution, and GBP 6.3 billion returned to shareholders.
Apr.16 by 2FIRSTS.ai
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai